Standard BioTools, Inc. (LAB)
0.7201
+0.03
(+4.06%)
USD |
NASDAQ |
Sep 09, 13:58
Standard BioTools Enterprise Value : -177.28M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | -177.28M |
| September 04, 2026 | -179.83M |
| September 03, 2026 | -184.38M |
| September 02, 2026 | -184.62M |
| September 01, 2026 | -193.56M |
| August 31, 2026 | -190.34M |
| August 28, 2026 | -196.93M |
| August 27, 2026 | -192.58M |
| August 26, 2026 | -193.05M |
| August 25, 2026 | -193.75M |
| August 24, 2026 | -193.75M |
| August 21, 2026 | -186.30M |
| August 20, 2026 | -195.20M |
| August 19, 2026 | -185.28M |
| August 18, 2026 | -189.05M |
| August 17, 2026 | -180.23M |
| August 14, 2026 | -169.28M |
| August 13, 2026 | -154.62M |
| August 12, 2026 | -137.25M |
| August 11, 2026 | -139.84M |
| August 10, 2026 | -139.33M |
| August 07, 2026 | -134.94M |
| August 06, 2026 | -134.90M |
| August 05, 2026 | -141.17M |
| August 04, 2026 | -126.90M |
| Date | Value |
|---|---|
| August 03, 2026 | -108.98M |
| July 31, 2026 | -108.27M |
| July 30, 2026 | -96.78M |
| July 29, 2026 | -105.96M |
| July 28, 2026 | -137.01M |
| July 27, 2026 | -144.90M |
| July 24, 2026 | -121.92M |
| July 23, 2026 | -105.41M |
| July 22, 2026 | -127.72M |
| July 21, 2026 | -101.96M |
| July 20, 2026 | -115.33M |
| July 17, 2026 | -97.72M |
| July 16, 2026 | -112.39M |
| July 15, 2026 | -118.58M |
| July 14, 2026 | -120.07M |
| July 13, 2026 | -115.80M |
| July 10, 2026 | -88.51M |
| July 09, 2026 | -80.90M |
| July 08, 2026 | -102.98M |
| July 07, 2026 | -96.15M |
| July 06, 2026 | -100.70M |
| July 02, 2026 | -90.66M |
| July 01, 2026 | -108.74M |
| June 30, 2026 | -126.03M |
| June 29, 2026 | -134.09M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Illumina, Inc. | 33.23B |
| Agilent Technologies, Inc. | 43.60B |
| Bio-Rad Laboratories, Inc. | 9.914B |
| Bruker Corp. | 10.55B |
| Danaher Corp. | 167.78B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -21.52M |
| Revenue (Quarterly) | 20.10M |
| Total Expenses (Quarterly) | 41.63M |
| EPS Diluted (Quarterly) | -0.0685 |
| Gross Profit Margin (Quarterly) | 52.40% |
| Profit Margin (Quarterly) | -107.1% |
| Earnings Yield | -31.32% |
| Normalized Earnings Yield | -23.08 |